Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)

ClinicalTrials.gov ID: NCT04773600

Public ClinicalTrials.gov record NCT04773600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 6:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.15% Administered QD in Subjects With Atopic Dermatitis

Study identification

NCT ID
NCT04773600
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Arcutis Biotherapeutics, Inc.
Industry
Enrollment
683 participants

Conditions and interventions

Interventions

  • Roflumilast Cream Drug
  • Vehicle cream Drug

Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 23, 2021
Primary completion
Sep 28, 2022
Completion
Sep 28, 2022
Last update posted
Oct 3, 2024

2021 – 2022

United States locations

U.S. sites
44
U.S. states
19
U.S. cities
41
Facility City State ZIP Site status
Arcutis Clinical Site 31 Birmingham Alabama 35244
Arcutis Clinical Site 51 Fort Smith Arkansas 72916
Arcutis Clinical Site 46 Inglewood California 90301
Arcutis Clinical Site 19 San Diego California 92123
Arcutis Clinical Site 36 San Diego California 92123
Arcutis Clinical Site 13 Santa Monica California 90404
Arcutis Clinical Site 54 Centennial Colorado 80112
Arcutis Clinical Site 55 Boca Raton Florida 33486
Arcutis Clinical Site 30 Coral Gables Florida 33146
Arcutis Clinical Site 37 Delray Beach Florida 33484
Arcutis Clinical Site 58 Miami Florida 33137
Arcutis Clinical Site 41 Miami Florida 33144
Arcutis Clinical Site 11 Sanford Florida 32771
Arcutis Clinical Site 57 West Palm Beach Florida 33406
Arcutis Clinical Site 62 Boise Idaho 83706
Clinical Site 04 Plainfield Indiana 46168
Arcutis Clinical Site 43 Louisville Kentucky 40241
Arcutis Clinical Site 63 Baton Rouge Louisiana 70808
Arcutis Clinical Site 42 Lake Charles Louisiana 70605
Arcutis Clinical Site 38 Mandeville Louisiana 70448
Arcutis Clinical Site 06 Metairie Louisiana 70006
Arcutis Clinical Site 34 Rockville Maryland 20850
Arcutis Clinical Site 29 Clinton Township Michigan 48038
Arcutis Clinical Site 21 Fort Gratiot Michigan 48059
Arcutis Clinical Site 61 Troy Michigan 48084
Arcutis Clinical Site 245 Saint Joseph Missouri 64506
Arcutis Clinical Site 53 New York New York 11415
Arcutis Clinical Site 39 Rochester New York 14623
Arcutis Clinical Site 33 Stony Brook New York 11790
Arcutis Clinical Site 01 High Point North Carolina 27262
Arcutis Clinical Site 24 Hershey Pennsylvania 17033
Arcutis Clinical Site 07 Pittsburgh Pennsylvania 15213
Arcutis Clinical Site 35 Charleston South Carolina 29407
Arcutis Clinical Site 18 Charleston South Carolina 29425
Arcutis Clinical Site 15 North Charleston South Carolina 29420
Clinical Site 05 Austin Texas 78759
Arcutis Clinical Site 03 College Station Texas 77845
Arcutis Clinical Site 59 Frisco Texas 75034
Arcutis Clinical Site 250 Grapevine Texas 76051
Arcutis Clinical Site 52 Pflugerville Texas 78660
Arcutis Clinical Site 02 San Antonio Texas 78213
Arcutis Clinical Site 32 Orem Utah 84058
Arcutis Clinical Site 22 Burke Virginia 22015
Arcutis Clinical Site 17 Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04773600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 3, 2024 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04773600 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →